Skip to Content

User Reviews for Brevibloc

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Learn more about Brevibloc.

Condition	Reviews	Compare	Avg. Ratings

Reviews for Brevibloc

No reviews have yet been submitted. Be the first to review this drug.

Learn more about

Micromedex® Care Notes:

More about Brevibloc (esmolol)

Consumer resources

Professional resources

Related treatment guides

Drug Status

Availability Rx Prescription only

Pregnancy Category C Risk cannot be ruled out

CSA Schedule N Not a controlled drug

Approval History Calendar Drug history at FDA

WADA Class WADA Anti-Doping Classification

FDA Consumer Updates

More FDA updates

Drug Class

Cardioselective beta blockers
Group II antiarrhythmics

Recently Approved

Amjevita Amjevita (adalimumab-atto) is an anti-TNF-α monoclonal antibody biosimilar to Humira, approved for ...
Exondys 51 Exondys 51 (eteplirsen) is an antisense oligonucleotide indicated for the treatment of Duchenne...
Kyleena Kyleena (levonorgestrel-releasing intrauterine system) is a low-dose progestin-containing...
Yosprala Yosprala (aspirin and omeprazole) is a platelet aggregation inhibitor and proton pump inhibitor...

Related News and Articles

Your Biological Clock: Why Some Age Faster Than Others September 28, 2016
Can Pregnancy Problems Foretell Future Health Risks? September 26, 2016
Sound Waves: An Rx for High Blood Pressure, Migraine? September 16, 2016

Related Questions & Answers

Brevibloc - who makes this product?

Read more questions...

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 2nd, 2016), Cerner Multum™ (updated Sep 5th, 2016), Wolters Kluwer™ (updated Aug 8th, 2016) and others. To view content sources and attributions, please refer to our editorial policy.